Ultraslow Full-power SWL Versus Slow Power-ramping SWL in Stones With High Attenuation Value
Not Applicable
Completed
- Conditions
- Renal Stones
- Registration Number
- NCT03763539
- Lead Sponsor
- Cairo University
- Brief Summary
Ultraslow full-power SWL versus slow power-ramping SWL in stones with high attenuation value
- Detailed Description
To evaluate the efficacy of ultraslow rate of SWL versus slow rate, power ramping SWL.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 196
Inclusion Criteria
- single renal stone less than or equal to 3 cm (2 cm for lower calyceal stones)
- radio-opaque stone
- high attenuation value (≥ 1000 HU) stone
Exclusion Criteria
- Abnormal renal anatomy
- renal insufficiency
- solitary kidney
- coagulopathies
- uncontrolled hypertension
- renal artery or aortic aneurysm
- active urinary tract infection
- pregnancy
- severe skeletal malformations (spinal deformity) precluding proper stone localization
- skin to stone distance (SSD) > 11 cm
- BMI > 30 Kgm/m2
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method stone free rate 3 months following last session of SWL Complete clearance of stones in addition to clinically insignificant residual fragments
- Secondary Outcome Measures
Name Time Method Complications 1 year following last session of SWL Comparison of complications in both groups
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SWL efficacy in high attenuation renal stones?
How does ultraslow full-power SWL compare to power-ramping SWL in renal stone clearance rates?
Which biomarkers correlate with successful SWL outcomes in calcium oxalate stone patients?
What are the adverse event profiles of ultraslow versus slow power-ramping SWL techniques?
Are there combination therapies that enhance SWL effectiveness for high CT attenuation urolithiasis?
Trial Locations
- Locations (1)
Beni-Suef Hospitals
🇪🇬Banī Suwayf, Outside U.S./Canada, Egypt
Beni-Suef Hospitals🇪🇬Banī Suwayf, Outside U.S./Canada, Egypt